The role of long‐term effects of allopurinol on cardiovascular outcomes and all‐cause mortality in diabetes.
S Abtahi - Diabetes, Obesity & Metabolism, 2019 - search.ebscohost.com
The role of long-term effects of allopurinol on cardiovascular outcomes and all-cause
mortality in diabetes I read with interest the recently published study in I Diabetes, Obesity …
mortality in diabetes I read with interest the recently published study in I Diabetes, Obesity …
Association between allopurinol and cardiovascular outcomes and all‐cause mortality in diabetes: a retrospective, population‐based cohort study
A Weisman, GA Tomlinson… - Diabetes, Obesity …, 2019 - Wiley Online Library
Aim To assess the association between allopurinol and mortality and cardiovascular
outcomes in an allopurinol‐treated diabetes cohort. Materials and Methods We conducted a …
outcomes in an allopurinol‐treated diabetes cohort. Materials and Methods We conducted a …
The effect of allopurinol on cardiovascular outcomes in patients with type 2 diabetes: a systematic review
E Bletsa, SA Paschou, V Tsigkou, PK Stampouloglou… - Hormones, 2022 - Springer
Background Cardiovascular disease (CVD) remains the main cause of death in patients with
type 2 diabetes (T2D). Although hyperuricemia has been associated with multiple CV …
type 2 diabetes (T2D). Although hyperuricemia has been associated with multiple CV …
[图书][B] Associations between allopurinol and cardiovascular and renal outcomes in diabetes
A Weisman - 2020 - search.proquest.com
Diabetes is a leading cause of cardiovascular and kidney disease, and novel therapies to
reduce these adverse diabetes outcomes are urgently required. Allopurinol, a uric acid …
reduce these adverse diabetes outcomes are urgently required. Allopurinol, a uric acid …
Allopurinol and cardiovascular outcomes in adults with hypertension
RL MacIsaac, J Salatzki, P Higgins, MR Walters… - …, 2016 - Am Heart Assoc
Allopurinol lowers blood pressure in adolescents and has other vasoprotective effects.
Whether similar benefits occur in older individuals remains unclear. We hypothesized that …
Whether similar benefits occur in older individuals remains unclear. We hypothesized that …
Effect of allopurinol on cardiovascular outcomes in hyperuricemic patients: a cohort study
KS Larsen, A Pottegård, HM Lindegaard… - The American journal of …, 2016 - Elsevier
Background Hyperuricemia and gout have been associated with increased cardiovascular
risk. Allopurinol is an effective urate-lowering drug. Whether lowering of urate by allopurinol …
risk. Allopurinol is an effective urate-lowering drug. Whether lowering of urate by allopurinol …
Impact of ALLopurInol on ENdothelial funCtion in diabEtic patients affected with coronary artery disease: ALLIENCE trial
S Kasbaoui, ZI Elhadj, M Boukhris - Archives of Cardiovascular Diseases …, 2022 - Elsevier
Background Allopurinol, a xanthine oxidase inhibitor, was shown to be useful in improving
endothelial dysfunction in diabetic patients independently from their coronary status …
endothelial dysfunction in diabetic patients independently from their coronary status …
Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes
JA Singh, R Ramachandaran, S Yu… - BMC cardiovascular …, 2017 - Springer
Background Few studies, if any, have examined cardiovascular outcomes in patients with
diabetes and gout. Both diabetes and gout are risk factors for cardiovascular disease. The …
diabetes and gout. Both diabetes and gout are risk factors for cardiovascular disease. The …
Allopurinol use and risk of non-fatal acute myocardial infarction
FJ de Abajo, MJ Gil, A Rodríguez, P García-Poza… - Heart, 2015 - heart.bmj.com
Objectives To quantify the risk of non-fatal acute myocardial infarction (AMI) among users of
allopurinol. Methods We carried out a population-based case–control study over the period …
allopurinol. Methods We carried out a population-based case–control study over the period …
Impact of urate level on cardiovascular risk in allopurinol treated patients. A nested case-control study
K Søltoft Larsen, A Pottegård, HM Lindegaard… - PLoS One, 2016 - journals.plos.org
Background Gout gives rise to increased risk of cardiovascular events. Gout attacks can be
effectively prevented with urate lowering drugs, and allopurinol potentially reduces …
effectively prevented with urate lowering drugs, and allopurinol potentially reduces …
相关搜索
- effect of allopurinol cardiovascular outcomes
- mortality in diabetes cardiovascular outcomes
- allopurinol use gout and diabetes
- effect of allopurinol hyperuricemic patients
- hyperuricemic patients cardiovascular outcomes
- adults with hypertension cardiovascular outcomes
- cause mortality cardiovascular outcomes
- allopurinol use patients with gout